Ionis Pharmaceuticals (IONS) Net Cash Flow Growth (3y) (2012 - 2026)
Ionis Pharmaceuticals (IONS) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | -50.33% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | 38.47% |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | 32.17% |
| 10 | Ionis Pharmaceuticals | 9.24 Bn | 7.32 Bn | 243.11 Mn | -101.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101.02% |
| Dec 31, 2025 | 42.10% |
| Sep 30, 2025 | 30.04% |
| Jun 30, 2025 | 53.42% |
| Mar 31, 2025 | 27.38% |
| Dec 31, 2024 | -33.69% |
| Sep 30, 2024 | -15.97% |
| Jun 30, 2024 | -33.21% |
| Mar 31, 2024 | -71.28% |
| Dec 31, 2023 | 30.04% |
| Sep 30, 2023 | -39.37% |
| Jun 30, 2023 | 38.11% |
| Mar 31, 2023 | 29.36% |
| Dec 31, 2022 | -27.85% |
| Sep 30, 2022 | -103.29% |
| Jun 30, 2022 | 41.97% |
| Mar 31, 2022 | -75.08% |
| Dec 31, 2021 | 46.98% |
| Sep 30, 2021 | 30.22% |
| Jun 30, 2021 | -36.09% |